Startups
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
Overview
Location
United States
Employees
1-10
Total raised
$131.6M
Founded date
2018
Investors 5
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Metaplanet Holdings | metaplanet.com | |
| Aug 21, 2022 | Y Combinator | ycombinator.com |
| Oct 6, 2021 | Mubadala Capital | mubadala.com |
| Apr 21, 2022 | Altitude Life Science Ventures | altitudelsv.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Apr 12, 2022 | Series A round | $68M | |
| Sep 15, 2020 | Seed round | $9.2M |
Mentions in press and media 15
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 9, 2025 | Ansa Biotechnologies: $54.4 Million Series B Raised To Transform DNA Synthesis | Ansa Biotechnologies, an emerging leader in the field of DNA synthesis, has announced the closing of a $45.2 million funding round. This financing also includes additional commitments totaling $9.2 million, positioning it as an oversubscrib... |
| Oct 2, 2025 | Ansa Biotechnologies Raises $54.4M in Series B Financing | Ansa Biotechnologies, an Emeryville, CA-based DNA synthesis company, raised $54.4M in Series B funding. The round was led by Cerberus Ventures with participation from Blue Water Life Science Advisors, Altitude Life Science Ventures, Fall Li... |
| Oct 1, 2025 | Ansa Biotechnologies Secures $54.4M in Series B | EMERYVILLE, CA, Ansa Biotechnologies announced that it has closed $45.2M and secured commitments for an additional $9.2M as part of a series B financing round. >> Click here for more funding data on Ansa Biotechnologies >> To e... |
| Apr 12, 2022 | Ansa Biotechnologies nabs $68M | Ansa Biotechnologies has raised $68 million in a round led by Northpond Ventures. The company is a developer of DNA synthesis technology designed to advance biological research processes. View round |
| Apr 11, 2022 | Ansa Biotechnologies Closes $68M Series A | EMERYVILLE,CA, Ansa Biotechnologies announced it has closed a Series A financing round of $68M led by Northpond Ventures. >> Click here for more funding data on Ansa Biotechnologies >> To export Ansa Biotechnologies funding ... |
| Apr 11, 2022 | Ansa Biotechnologies Closes $68M Series A Financing | Ansa Biotechnologies, an Emeryville, CA-based developer of an enzymatic DNA synthesis technology, raised $68m in Series A financing. The round was led by Northpond Ventures, with participation from new investors RA Capital, Blue Water Life ... |
| Apr 11, 2022 | Paradigm, Andreessen Horowitz, and Union Square Ventures sued over alleged ‘rampant fraud’ on Uniswap exchange | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. The most successful crypto funds have taken a hands-on approach with the founders they work with.... |
| Sep 17, 2020 | Ansa Biotechnologies wants to usher in a new era of DNA manufacturing | Daniel Arlow has spent the last eighteen years studying genomics and synthetic biology. The arc of his career has taken the first-time founder of the new startup Ansa Biotechnologies from MIT to the famous Keasling Lab at the University of ... |
| Sep 15, 2020 | Ansa Biotechnologies Announces $9.2M in Seed and Pre-Seed Financing | Ansa Biotechnologies, a Berkeley, Calif.-based DNA synthesis tech service company, raised $7.9m in seed funding. The round was led by Horizons Ventures, with participation from Mubadala Capital, Humboldt Fund, and additional investors. Comb... |
Show more
Reviews 0
FAQ about Ansa Biotechnologies, Inc.
When was Ansa Biotechnologies, Inc. founded?
Ansa Biotechnologies, Inc. was founded in 2018.
How much funding has Ansa Biotechnologies, Inc. raised?
Ansa Biotechnologies, Inc. has raised $131.6M in total across 3 funding rounds.
What funding rounds has Ansa Biotechnologies, Inc. raised?
Parsers VC lists 3 funding rounds of Ansa Biotechnologies, Inc., among them a Series A round of $68M on Apr 12, 2022 and a seed round of $9.2M on Sep 15, 2020.
Who has invested in Ansa Biotechnologies, Inc.?
Parsers VC lists 5 investors of Ansa Biotechnologies, Inc., among them Y Combinator, Altitude Life Science Ventures and Mubadala Capital.
What has the press written about Ansa Biotechnologies, Inc.?
Parsers VC has collected 15 articles mentioning Ansa Biotechnologies, Inc., among them “Ansa Biotechnologies: $54.4 Million Series B Raised To Transform DNA Synthesis” (Oct 9, 2025) and “Ansa Biotechnologies Raises $54.4M in Series B Financing” (Oct 2, 2025).
Is Ansa Biotechnologies, Inc. still active?
Yes, Ansa Biotechnologies, Inc. is active; its latest activity on Parsers VC dates from Oct 13, 2025.